Kinshasa scales up its Ebola response
In the Democratic Republic of the Congo, the fight against Ebola is not taking place only in treatment centres. It is also under way on the roads of Ituri, in the neighbourhoods of Kisangani and in the corridors of public health institutions in Kinshasa. When an outbreak spreads, every day counts, especially in a country where distances, local insecurity and pressure on healthcare facilities complicate the response.
This time, vaccination has become one of the central tools in the response. Congolese health authorities have accelerated the campaign launched about two weeks ago. They are now seeking to broaden vaccine coverage, after Kinshasa initially requested 500,000 doses. That figure reflects the scale of the threat, as well as the determination to prevent the epidemic from becoming entrenched in the east of the country.
An epidemic spreading beyond its initial outbreak
The health ministry’s latest situation report, dated 9 September 2026 and published on 10 September, shows that transmission remains active. A total of 6,942 confirmed cases and 3,349 deaths have been recorded since the start of this 17th epidemic, giving a case fatality rate of 48.2%. The report notes 99 new cases in 24 hours, mainly in Ituri and North Kivu. It also reports geographical spread to South Ubangi, indicating that close surveillance must continue well beyond the initial outbreak area.
The outbreak remains concentrated along the Ituri–North Kivu corridor, which accounts for most new cases. Ituri remains the epicentre, with 5,508 confirmed cases and 2,501 deaths. North Kivu follows, with 1,139 confirmed cases and 725 deaths. Haut-Uele, Tshopo, South Kivu and Bas-Uele remain affected to varying degrees. The distribution points to a simple reality: the response cannot be confined to individual provinces. It must be mobile, co-ordinated and swift.
The vaccination campaign began with the available doses, initially targeting frontline health workers and contacts of confirmed cases. In Tshopo, 1,779 people had already been vaccinated out of 11,000 targeted, or 16.2%. Meanwhile, 2,500 doses had been deployed to health zones, while some of the stock remains in the central warehouse. In Ituri, preparations to vaccinate frontline workers are continuing in Bunia. These figures show an operation still being scaled up, rather than a fully established programme.
Why vaccination remains crucial despite limited supplies
The vaccine used in the response is valuable, but it does not resolve every uncertainty. The virus responsible for this outbreak is Bundibugyo, a strain for which the evidence base is less robust than for other forms of Ebola. This is one reason health teams are proceeding cautiously, combining vaccination with clinical research, isolation, case management and contact tracing.
The first batch of doses received by the DRC was used to begin protecting exposed health workers and people around transmission hotspots. But the actual need exceeds this initial supply. The authorities had requested a much larger quantity to cover more areas and prepare for chains of transmission. The gradual arrival of doses is allowing coverage to expand, but does not yet fully meet the scale of the epidemic.
On the ground, vaccination is only one part of the response. The health report also highlights overcrowding in treatment facilities in North Kivu, where available beds are not always sufficient to accommodate patients. It also notes that deaths in the community persist, a worrying indicator that often reflects delays in seeking care, difficulties accessing treatment or local mistrust of health services. In an Ebola epidemic, these factors weigh as heavily as the virus itself.
Local engagement therefore remains essential. In Ituri, North Kivu, Haut-Uele and Tshopo, response teams are stepping up home visits, educational discussions and exchanges with local authorities and community representatives. This quiet work is often decisive. It helps build trust, identify alerts and reduce delays between the first symptoms and isolation.
What this phase means for the DRC and the region
The situation in the DRC is a reminder of a constant in public health in Central Africa: when an epidemic spreads through areas crossed by commercial, human and sometimes armed flows, it quickly becomes a regional concern. The DRC shares borders with several countries affected by population movements. An outbreak that is not contained could therefore become a cross-border risk, particularly if community alerts and border surveillance remain uneven.
The health ministry, the National Institute of Public Health, the WHO, Africa CDC and humanitarian partners have built a joint response, but the speed of transmission demands continuous co-ordination. In this kind of crisis, the challenge is not only medical. It is also logistical, social and institutional. A vaccination chain cannot operate without fuel, cold chains, trained staff and local trust.
For families, the impact is immediate: fear, additional expenses, travel to more distant centres and disruption to daily activities. In cities such as Kisangani and Bunia, the epidemic adds further pressure on markets, transport and healthcare facilities. In rural areas, it deepens isolation and sometimes delays care. For the Congolese state, it tests its ability to act quickly, in the right place, with stocks still limited and health pressures showing no sign of easing.
At continental level, this phase matters to all of Central Africa, as well as the African Union and its health bodies. It raises a broader question: how can an emergency response be turned into a lasting system of preparedness? The DRC has extensive experience of Ebola outbreaks. That institutional memory is an asset. But the current scale shows that surveillance, clinical research and rapid access to doses still need to be strengthened. Only then can vaccination move beyond emergency status and become a genuine collective shield.



